The genetics of the persistent infection and demyelinating disease caused by Theiler's virus

Annual Review of Microbiology

Volumn 59, Issue , 2005, Pages 279-298

  Brahic, Michel ^a   Bureau, Jean François ^a   Michiels, Thomas ^b  

^a INSTITUT PASTEUR   (France)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

CNS; Interferon; Picornavirus; Quantitative trait locus; TMEV

Indexed keywords

INTERFERON; ZINC FINGER PROTEIN;

CENTRAL NERVOUS SYSTEM INFECTION; CYTOTOXIC T LYMPHOCYTE; DEMYELINATING DISEASE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETICS; GLIA CELL; INBRED STRAIN; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; OLIGODENDROGLIA; OPEN READING FRAME; PERSISTENT VIRUS INFECTION; PICORNAVIRUS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; VIROGENESIS; VIRUS GENOME;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVIRUS INFECTIONS; CENTRAL NERVOUS SYSTEM DISEASES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; QUANTITATIVE TRAIT LOCI; THEILOVIRUS; VIRAL PROTEINS;

ANIMALIA; PICORNAVIRIDAE; THEILER VIRUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 27144467078     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.59.030804.121242     Document Type: Review

References (107)

1. Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Virol. 77:4646-57
2. Alley J, Khasabov S, Simone D, Beitz A, Rodriguez M, Njenga MK. 2003. More severe neurologic deficits in SJL/J male than female mice following Theiler's virus-induced CNS demyelination. Exp. Neurol. 180:14-24
3. Asakura K, Murayama H, Himeda T, Ohara Y. 2002. Epitope-tagged L* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection. J. Virol. 76:13049-54
4. Aubagnac S, Brahic M, Bureau J-F. 1999. Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J. Virol. 73:7965-71
5. Aubagnac S, Brahic M, Bureau J-F. 2002. Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection. J. Virol. 76:5807-12
6. Aubert C, Chamorro M, Brahic M. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3:319-26
7. b gene become resistant to persistent infection by Theiler's virus. J. Virol. 68:4049-52
8. b genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J. Gen. Virol. 82:1043-47
9. Badshah C, Calenoff MA, Rundell K. 2000. The leader polypeptide of Theiler's murine encephalomyelitis virus is required for the assembly of virions in mouse L cells. J. Virol. 74:875-82
10. Belov GA, Lidsky PV, Mikitas OV, Egger D, Lukyanov KA, et al. 2004. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J. Virol. 78:10166-77
11. Benedict CA, Norris PS, Ware CF. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3:1013-18
12. Bihl F, Brahic M, Bureau J-F. 1999. Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system. Genetics 152:385-92
13. Bihl F, Pena-Rossi C, Guénet J-L, Brahic M, Bureau J-F. 1997. The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J. Virol. 71:5025-30
14. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, et al. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78:9798-806
15. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71:5244-50
16. Brahic M. 2002. Theiler's virus infection of the mouse, or: of the importance of studying animal models. Virology 301:1-5
17. Brahic M, Stroop WG, Baringer JR. 1981. Theiler's virus persists in glial cells during demyelinating disease. Cell 26:123-28
18. Bureau J-F, Montagutelli X, Bihl F, Lefebvre S, Guénet J-L, Brahic M. 1993. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:87-91
19. Bureau J-F, Montagutelli X, Lefebvre S, Guénet J-L, Pla M, Brahic M. 1992. The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J. Virol. 66:4698-704
20. Butterfield RJ, Roper RJ, Rhein DM, Melvold RW, Haynes L, et al. 2003. Sex-specific quantitative trait loci govern susceptibility to Theiler's murine encephalomyelitis virus-induced demyelination. Genetics 163:1041-46
21. Calenoff MA, Badshah CS, Dal Canto MC, Lipton HL, Rundell MK. 1995. The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells. J. Virol. 69:5544-49
22. Calenoff MA, Faaberg KS, Lipton HL. 1990. Genomic regions of neurovirulence and attenuation in Theiler's murine encephalomyelitis virus. Proc. Natl. Acad. Sci. USA 87:978-82
23. Cash E, Bandeira A, Chirinian S, Brahic M. 1989. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. J. Immunol. 143:984-88
24. Chen HH, Kong WP, Roos RP. 1995. The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J. Virol. 69:8076-78
25. Ciatto C, Tissot AC, Tschopp M, Capitani G, Pecorari F, et al. 2001. Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides. J. Mol. Biol. 312:1059-71
26. Clatch RJ, Melvold RW, Miller SD, Lipton HL. 1985. Theiler's murine encephalomyelitis virus (TMEV) induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1408-13
27. Croxford JL, Olson JK, Miller SD. 2002. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun. Rev. 1:251-60
28. Delhaye S, van Pesch V, Michiels T. 2004. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78:4357-62
29. Dethlefs S, Brahic M, Larsson-Sciard EL. 1997. An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. J. Virol. 71:8875-78
30. Dethlefs S, Escriou N, Brahic M, van der Werf S, Larsson-Sciard E-L. 1997. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J. Virol. 71:5361-65
31. Drescher KM, Pease LR, Rodriguez M. 1997. Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol. Rev. 159:177-93
32. Dumoutier L, Louahed J, Renauld JC. 2000. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164:1814-19
33. Dvorak CM, Hall DJ, Hill M, Riddle M, Pranter A, et al. 2001. Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection, and affects the efficiency of genome translation. Virology 290:261-71
34. Encinas JA, Lees MB, Sobel RA, Symonowicz C, Weiner HL, et al. 2001. Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int. Immunol. 13:257-64
35. Fiette L, Aubert C, Muller U, Huang S, Aguet M, et al. 1995. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:2069-76
36. Fu J, Stein S, Rosenstein L, Bodwell T, Routbort M, et al. 1990. Neurovirulence determinants of genetically engineered Theiler's virus. Proc. Natl. Acad. Sci. USA 87:4125-29
37. Gerety SJ, Karpus WJ, Cubbon AR, Goswami RG, Rundell MK, et al. 1994. Class restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J. Immunol. 152:908-18
38. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919-29
39. Ghadge GD, Ma L, Sato S, Kim J, Roos RP. 1998. A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J. Virol. 72:8605-12
40. Gurney AL. 2004. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int. Immunopharmacol. 4:669-77
41. Gustin KE, Sarnow P. 2001. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J. 20:240-49
42. Hill KE, Pigmans M, Fujinami RS, Rose JW. 1998. Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J. Neuroimmunol. 85:44-51
43. Hoffman MA, Palmenberg AC. 1996. Revertant analysis of J-K mutations in the encephalomyocarditis virus internal ribosomal entry site detects an altered leader protein. J. Virol. 70:6425-30
44. Jarousse N, Syan S, Martinat C, Brahic M. 1998. The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability to infect cultured neurons. J. Virol. 72:7213-20
45. Jarousse N, Viktorova EG, Pilipenko EV, Agol VI, Brahic M. 1999. An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system. J. Virol. 73:801-41.
46. Jnaoui K, Minet M, Michiels T. 2002. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J. Virol. 76:8138-47
47. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, et al. 1999. Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 73:3702-8
48. Kang BS, Lyman MA, Kim BS. 2002. Differences in avidity and epitope recognition of CD8(+) T cells infiltrating the central nervous systems of SJL/J mice infected with BeAn and DA strains of Theiler's murine encephalomyelitis virus. J. Virol. 76:11780-84
49. Kang BS, Lyman MA, Kim BS. 2002. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional. J. Virol. 76:6577-85
50. Kappel CA, Melvold RW, Kim BS. 1990. Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis. J. Neuroimmunol. 29:15-19
51. Kim BS, Palma JP, Kwon D, Fuller AC. 2005. Innate immune response induced by Theiler's murine encephalomyelitis virus infection. Immunol. Res. 31:1-12
52. Kim BS, Palna JP. 1999. Immune mechanisms of Theiler's virus-induced demyelination. Exp. Mol. Med. 31:115-21
53. Kong WP, Ghadge GD, Roos RP. 1994. Involvement of cardiovirus leader in host cell-restricted virus expression. Proc. Natl. Acad. Sci. USA 91:1796-800
54. Kong WP, Roos RP. 1991. Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 65:3395-99
55. Lander E, Kruglyak L. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:241-47
56. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM. 2004. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116:541-50
57. Lipton HL, Melvold RW. 1984. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132:1821-25
58. Lipton HL, Pritchard AE, Calenoff MA. 1998. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system. J. Gen. Virol. 79:1001-4
59. Lipton HL, Twaddle G, Jelachich ML. 1995. The predominant virus antigen burden is present in macrophages hi Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:2525-33
60. Lyman MA, Lee HG, Kang BS, Kang HK, Kim BS. 2002. Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles. J. Virol. 76:3125-34
61. Lyman MA, Myoung J, Mohindru M, Kim BS. 2004. Quantitative, not qualitative, differences in CD8(+) T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice. Eur. J. Immunol. 34:2730-39
62. Mamane Y, Heylbroeck C, Genin P, Algarte M, Servant MJ, et al. 1999. Interferon regulatory factors: the next generation. Gene 237:1-14
63. Martinat C, Mena N, Brahic M. 2002. Theiler's virus infection of primary cultures of bone marrow derived monocytes/macrophages. J. Virol. 76:12823-33
64. McAllister A, Tangy F, Aubert C, Brahic M. 1990. Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J. Virol. 64:4252-57.
65. Erratum. 1993. J. Virol. 67:2427
66. McCright IJ, Tsunoda I, Whitby FG, Fujinami RS. 1999. Theiler's viruses with mutations in loop I of VPI lead to altered tropism and pathogenesis. J. Virol. 73:2814-24
67. Mena I, Roussarie JP, Brahic M. 2004. Infection of macrophage primary cultures by persistent and nonpersistent strains of Theiler's virus: role of capsid and noncapsid viral determinants. J. Virol. 78:13356-61
68. Michiels T, Jarousse N, Brahic M. 1995. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 214:550-58
69. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch ML, et al. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-36
70. Monteyne P, Bureau J-F, Brahic M. 1997. The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 159:163-76
71. Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, et al. 1998. Perforin-dependent neurologic injury in a viral of multiple sclerosis. J. Neurosci. 18:7306-14
72. Murray PD, McGavern DB, Pease LR, Rodriguez M. 2002. Cellular sources and targets of IFN-g-mediated protection against viral demyelination and neurological deficits. Eur. J. Immunol. 32:606-15
73. Neville KL, Padilla J, Miller SD. 2002. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS. J. Neuroimmunol. 123:18-29
74. Njenga MK, Asakura K, Hunter SF, Wettstein P, Pease LR, Rodriguez M. 1997. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 71:8592-601
75. Njenga MK, Pease LR, Wettstein P, Mak T, Rodriguez M. 1997. Interferon alpha/beta mediates early virus-induced expression of H-2 D and H-2K in the central nervous system. Lab. Invest. 77:71-84
76. Obuchi M, Ohara Y, Takegami T, Murayama T, Takada H, Iizuka H. 1997. Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line. J. Virol. 71:729-33
77. Obuchi M, Yamamoto J, Uddin N, Odagiri T, Iizuka H, Ohara Y. 1999. Theiler's murine encephalomyelitis virus (TMFV) subgroup strain-specific infection in neural and non-neural cell lines. Microbiol. Immunol. 43:885-92
78. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD. 2004. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 17:174-207
79. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:3916-24
80. Ozden S, Aubert C, Bureau JF, Gonzalez-Dunia D, Brahic M. 1993. Analysis of proteolipid protein and P0 transcripts in mice infected with Theiler's virus. Microb. Pathog. 14:123-31
81. PenaRossi C, Delcroix M, Huitinga I, McAllister A, van Rooijen N, et al. 1997. Role of macrophages during Theiler's virus infection. J. Virol. 71:3336-40
82. Pena Rossi C, McAllister A, Tanguy M, Kägi D, Brahic M. 1998. Theiler's virus infection of perforin-deficient mice. J. Virol. 72:4515-19
83. Pilipenko EV, Viktorova EG, Guest ST, Agol VI, Roos RP. 2001. Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J. 20:6899-908
84. Racaniello VR. 2001. Picornaviridae: the viruses and their replication. In Field's Virology, ed. KM Knipe, PM Howley, pp. 685-722. Philadelphia: Lippincott Williams & Wilkins
85. Radaeva S, Sun R, Pan HN, Hong F, Gao B. 2004. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39:1332-42
86. Reddi HV, Lipton HL. 2002. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. J. Virol. 76:8400-7
87. Rodriguez M, Leibowitz J, David CS. 1986. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 163:620-31
88. Rodriguez M, Leibowitz JL, Lampert PW. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:426-33
89. Rodriguez M, Zoecklein LJ, Howe CL, Pavelko KD, Gamez JD, et al. 2003. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. J. Virol. 77:12252-65
90. Sato S, Reiner SL, Jensen MA, Roos RP. 1997. Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J. Neuroimmunol. 76:213-23
91. Schlitt BP, Felrice M, Jelachich ML, Lipton HL. 2003. Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions. J. Virol. 77:4383-88
92. Shah AH, Lipton HL. 2002. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment. Virology 304:443-50
93. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-64
94. Takata H, Obuchi M, Yamamoto J, Odagiri T, Roos RP, et al. 1998. L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J. Virol. 72:4950-55
95. Tsunoda I, Kuang LQ, Libbey JE, Fujinami RS. 2003. Axonal injury heralds virus-induced demyelination. Am. J. Pathol. 162:1259-69
96. Tsunoda I, Wada Y, Libbey JE, Cannon TS, Whitby FG, Fujinami RS. 2001. Prolonged gray matter disease without demyelination caused by Theilèr's murine encephalomyelitis virus with a mutation in VP2 puff B. J. Virol. 75:7494-505
97. van Eyll O, Michiels T. 2000. Influence of the Theiler's virus L* protein on macrophage infection, viral persistence, and neurovirulence. J. Virol. 74:9071-77
98. van Eyll O, Michiels T. 2002. Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J. Virol. 76:10665-73
99. van Pesch V, Michiels T. 2003. Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J. Biol. Chem 278:46321-28
100. van Pesch V, van Eyll O, Michiels T. 2001. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:7811-17
101. Vigneau S, Rohrlich P-S, Brahic M, Bureau J-F. 2003. TmevpgI, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon. J. Virol. 77:5632-38
102. Weber F, Kochs G, Haller O. 2004. Inverse interference: how viruses fight the interferon system. Viral Immunol. 17:498-515
103. Wolk K, Kunz S, Asadullah K, Sabat R. 2002. Immune cells as sources and targets of the IL-10 family members? J. Immunol. 168:5397-402
104. Yamasaki K, Weihl CC, Roos RP. 1999. Alternative translation initiation of Theiler's murine encephalomyelitis virus. J. Virol. 73:8519-26
105. Zhou L, Luo Y, Wu Y, Tsao J, Luo M. 2000. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J. Virol. 74:1477-85
106. Zoll J, Galama JM, van Kuppeveld FJ, Melchers WJ. 1996. Mengovirus leader is involved in the inhibition of host cell protein synthesis. J. Virol. 70:4948-52
107. Zoll J, Melchers WJ, Galama JM, van Kuppeveld FJ. 2002. The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kappa B. J. Virol. 76:9664-72